https://www.selleckchem.com/mTOR.html
47(P0.02 95%CI 1.40-2.31) while one study with the poor functional outcome at discharge was OR=2.49. In patients with acute ischemic stroke, elevated neutrophil-to-lymphocyte correlates with poorer functional outcome and increased chances of developing symptomatic Intracranial Hemorrhage. Baseline neutrophil-to-lymphocyte can be an inexpensive and easily available biomarker, especially in resource-poor settings, for predicting clinical outcomes in patients with ischemic stroke. In patients with acute ischemic stroke, elevated neutrophil-to-lymp